Impact of Express study on clinical practice in ARDS patients: a single French ICU experience

Annales Françaises D'anesthèsie Et De Rèanimation
C BoutinJ Y Lefrant

Abstract

The French Express study compared two alveolar recruitment managements (maximal versus standard) in Acute Respiratory Distress Syndrome (ARDS) patients ventilated with 6 ml/kg of ideal body weight (IBW). The objective of the present study was to assess in a single intensive care unit, the impact of Express study on the mechanical ventilation settings in non-included ARDS patients. From 16 October 2002 to 14 January 2005 all consecutive eligible but non-included patients in Express study were studied. The maximal and minimal tidal volumes, and the minimal and maximal respiratory rates were retrospectively recorded. These parameters were compared according to the date of patient's admission and then the patients were separated in four quartiles (14, 15, 15, 15 patients). From the first to the last study period separated by 26 months, the mean maximal tidal volume decreased from 9.0+/-1.3 to 7.4+/-1.0 ml/kg of IBW (p=0.03), the proportion of patients ventilated with a maximal tidal volume greater than 8 ml/kg decreased from 93% to 20% (p<0.01), the median minimal respiratory rate increased from 14 to 18 b/min (p=0.03) and the proportion of patients with a respiratory rate less than 20 b/min decreased from 100% to 73% (p<0.01). The...Continue Reading

References

Mar 1, 1994·American Journal of Respiratory and Critical Care Medicine·G R BernardR Spragg
Feb 5, 1998·The New England Journal of Medicine·M B AmatoC R Carvalho
May 4, 2000·The New England Journal of Medicine·UNKNOWN Acute Respiratory Distress Syndrome NetworkArthur Wheeler
May 4, 2000·The New England Journal of Medicine·L B Ware, M A Matthay
Jun 30, 2001·The New England Journal of Medicine·M J Tobin
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
Feb 8, 2003·American Journal of Respiratory and Critical Care Medicine·Craig R WeinertWilliam A Marinelli
Aug 28, 2003·American Journal of Respiratory and Critical Care Medicine·Marcelo AmatoRoy Brower
Apr 20, 2004·Critical Care Medicine·R Phillip DellingerUNKNOWN Surviving Sepsis Campaign Management Guidelines Committee
Jun 10, 2004·Critical Care Medicine·Gordon D RubenfeldLeonard D Hudson
Jun 29, 2004·Anesthesiology·Jean-Jacques RoubyQin Lu
Jul 23, 2004·The New England Journal of Medicine·Roy G BrowerUNKNOWN National Heart, Lung, and Blood Institute ARDS Clinical Trials Network
Jan 25, 2005·American Journal of Respiratory and Critical Care Medicine·Salvatore GrassoTommaso Fiore
Nov 12, 2005·Intensive Care Medicine·Rosel TallachDavid R Ball
Dec 24, 2005·Critical Care Medicine·Djillali AnnaneUNKNOWN Ger-Inf-05 Study Group
Oct 27, 2007·American Journal of Respiratory and Critical Care Medicine·Andrés EstebanUNKNOWN VENTILA Group
Feb 14, 2008·JAMA : the Journal of the American Medical Association·Alain MercatUNKNOWN Expiratory Pressure (Express) Study Group
Mar 22, 2008·American Journal of Respiratory and Critical Care Medicine·William CheckleyUNKNOWN Acute Respiratory Distress Syndrome Network Investigators

❮ Previous
Next ❯

Citations

Nov 5, 2011·Annales Françaises D'anesthèsie Et De Rèanimation·V ReubrechtL Muller
Feb 7, 2015·Critical Care : the Official Journal of the Critical Care Forum·Matthieu BiaisUNKNOWN AzuRea Group
Apr 27, 2019·Canadian Journal of Occupational Therapy. Revue Canadienne D'ergothérapie·Alexandre PatryEmmanuelle Careau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.